Information Provided By: 
Fly News Breaks for June 13, 2016
QDEL
Jun 13, 2016 | 06:45 EDT
Raymond James analyst Nicholas Jansen upgraded Quidel to Outperform and established a $21.50 price target. The analyst said Quidel risk/reward is attractive now that shares are down more than 30% below their 52-week high and the weak 2015/2016 flue season is behind it. Jansen sees multiple new product catalysts over the next nine months that include the Sofia 2 launch, multiple Solana assay approvals, and Vitamin D/Lyme assays on Sofia. Also, Jansen believes a more normalized flu season could result in upside to consensus estimates.
News For QDEL From the Last 2 Days
There are no results for your query QDEL
